Stellantis NV announced a major investment push focused on four core brands in a broad reset to boost profitability.

We tested both on writing, coding, research, and video. See which one fits your workflow, budget, and use case.

The consultation outlines a fundamentally new approach to how rare disease therapies are tested, licensed and monitored. The aim is clear: to make it quicker, safer, and less costly to bring ...